Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.
about
177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice.Liposomal nanostructures for photosensitizer delivery.Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cellsImpact of photosensitizers activation on intracellular trafficking and viscosity.PSMA-targeted SPECT agents: mode of binding effect on in vitro performance.Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigenA high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.From AR to c-Met: androgen deprivation leads to a signaling pathway switch in prostate cancer cells.Prolonged androgen deprivation leads to overexpression of calpain 2: implications for prostate cancer progression.Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cellsThe role of cytoskeleton and adhesion proteins in the resistance to photodynamic therapy. Possible therapeutic interventions.Effect of Porphyrin Sensitizer MgTPPS4 on Cytoskeletal System of HeLa Cell Line-Microscopic Study.Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.Evaluation of photodynamic therapy in adhesion protein expression.A PSMA-targeted theranostic agent for photodynamic therapy.
P2860
Q33821017-1E3D3BF4-1D87-4D2C-A317-F11CD0A407C8Q34068206-F855D962-D678-4DE4-B8AA-7361A0F628A8Q34068220-AC5F0B06-C8D4-448D-91AF-00898EF8B9D0Q34541354-76888081-5EF3-4E78-B741-1B29805BCC21Q35081062-3AEDB587-397C-42C1-AFA2-A1BE6BB99CC2Q35552454-7466C053-C507-45F2-B775-18A7754588FBQ35926706-A65261AC-D2F6-499A-82DE-5A81ACCE16CEQ36219010-1F2CA917-255F-4B38-8FD0-CC68D1B3B444Q36477594-2A2C4FEA-C07E-407E-AD1B-FE10EF60B802Q36501550-175D8B7C-026C-41CB-AA52-E776AE3A086EQ36643062-FE6E9B28-F09E-42EE-9F61-19E764AFE335Q37313321-8E1FF18B-D095-4FCA-9157-2A7FE09F481DQ37504520-F91E4A39-8DF3-4622-9131-42B44FD888D6Q37591940-8DC9F20C-2C2C-47C6-AF95-424C78750469Q38400490-24F28C42-1B22-4899-8CE6-F1B3E5D8B8E4Q38763222-6BD9A68B-4C0B-489E-8498-DA7C2D9AE16EQ38820744-C65E9AFC-382B-4C77-A1E1-5E67AE4DACB6Q42720170-E851DB80-EC67-4F70-AF53-D9DC9069D5F4Q49953699-C653A4E9-A62C-437B-86DB-BEC9830D930D
P2860
Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@ast
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@en
type
label
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@ast
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@en
prefLabel
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@ast
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@en
P2093
P2860
P1433
P1476
Prostate-specific membrane ant ...... rapid cytoskeletal disruption.
@en
P2093
Clifford E Berkman
Tiancheng Liu
P2860
P304
P356
10.1016/J.CANLET.2010.04.003
P407
P577
2010-05-08T00:00:00Z